Multiple insiders at Aurinia Pharmaceuticals Inc. (AUPH) have recently acquired a significant stake in the company. Over the past week, five insiders collectively purchased approximately $12.67 million worth of AUPH shares.
The most notable activity comes from Kevin Tang, who executed several transactions totaling over $12.67 million. These purchases represent a substantial investment by individuals with intimate knowledge of the company's operations and prospects.
This concentrated insider buying is often viewed as a strong positive indicator by market observers, suggesting confidence in the company's future performance.